1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chiva, C.
Barthe, P.
Codina, A.
Giralt, E.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
125
1508
1517
10.1021/ja0207908
12568610
Synthesis and NMR structure of P41ICF, a potent inhibitor of human cathepsin L
2003
10.2210/pdb1l3h/pdb
pdb_00001l3h
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
7261.075
MHC CLASS II-ASSOCIATED P41 INVARIANT CHAIN FRAGMENT (P41icf)
THYROGLOBULIN-LIKE DOMAIN
1
syn
polymer
HLA class II histocompatibility antigen, gamma chain
no
no
LTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSES
LTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSES
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-03-04
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
1ICF contains the same protein complexed with Cathepsin L.
RCSB
Y
RCSB
2002-02-27
REL
REL
This sequence occurs naturally in humans.
sample
This structure was determined using standard 2D homonuclear techniques.
structures with the lowest energy,target function
600
30
DQF-COSY
2D TOCSY
2D NOESY
5.7
ambient
288
K
the structures are based on a total of 981 restraints, 925 are NOE-derived distance constraints, 56 dihedral angle restraints
torsion angle dynamics and simulated annealing with restrained molecular dynamics
1
fewest violations
1mM P41icf; 20mM phosphate buffer, 0.01mM NaN3
85% H20, 15% D2O
Delaglio
processing
NMRPipe
Johnson
data analysis
NMRView
Guntert
structure solution
DYANA
1.5
Case
refinement
Amber
5.0
800
Bruker
DRX
600
Bruker
DRX
LEU
1
n
1
LEU
1
A
THR
2
n
2
THR
2
A
LYS
3
n
3
LYS
3
A
CYS
4
n
4
CYS
4
A
GLN
5
n
5
GLN
5
A
GLU
6
n
6
GLU
6
A
GLU
7
n
7
GLU
7
A
VAL
8
n
8
VAL
8
A
SER
9
n
9
SER
9
A
HIS
10
n
10
HIS
10
A
ILE
11
n
11
ILE
11
A
PRO
12
n
12
PRO
12
A
ALA
13
n
13
ALA
13
A
VAL
14
n
14
VAL
14
A
HIS
15
n
15
HIS
15
A
PRO
16
n
16
PRO
16
A
GLY
17
n
17
GLY
17
A
SER
18
n
18
SER
18
A
PHE
19
n
19
PHE
19
A
ARG
20
n
20
ARG
20
A
PRO
21
n
21
PRO
21
A
LYS
22
n
22
LYS
22
A
CYS
23
n
23
CYS
23
A
ASP
24
n
24
ASP
24
A
GLU
25
n
25
GLU
25
A
ASN
26
n
26
ASN
26
A
GLY
27
n
27
GLY
27
A
ASN
28
n
28
ASN
28
A
TYR
29
n
29
TYR
29
A
LEU
30
n
30
LEU
30
A
PRO
31
n
31
PRO
31
A
LEU
32
n
32
LEU
32
A
GLN
33
n
33
GLN
33
A
CYS
34
n
34
CYS
34
A
TYR
35
n
35
TYR
35
A
GLY
36
n
36
GLY
36
A
SER
37
n
37
SER
37
A
ILE
38
n
38
ILE
38
A
GLY
39
n
39
GLY
39
A
TYR
40
n
40
TYR
40
A
CYS
41
n
41
CYS
41
A
TRP
42
n
42
TRP
42
A
CYS
43
n
43
CYS
43
A
VAL
44
n
44
VAL
44
A
PHE
45
n
45
PHE
45
A
PRO
46
n
46
PRO
46
A
ASN
47
n
47
ASN
47
A
GLY
48
n
48
GLY
48
A
THR
49
n
49
THR
49
A
GLU
50
n
50
GLU
50
A
VAL
51
n
51
VAL
51
A
PRO
52
n
52
PRO
52
A
ASN
53
n
53
ASN
53
A
THR
54
n
54
THR
54
A
ARG
55
n
55
ARG
55
A
SER
56
n
56
SER
56
A
ARG
57
n
57
ARG
57
A
GLY
58
n
58
GLY
58
A
HIS
59
n
59
HIS
59
A
HIS
60
n
60
HIS
60
A
ASN
61
n
61
ASN
61
A
CYS
62
n
62
CYS
62
A
SER
63
n
63
SER
63
A
GLU
64
n
64
GLU
64
A
SER
65
n
65
SER
65
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLN
33
A
N
GLN
33
A
O
TRP
42
A
O
TRP
42
1
A
A
HG1
O
THR
GLY
2
27
1.49
1
A
A
O
HG
GLN
SER
5
9
1.54
1
A
A
O
HG
SER
SER
18
37
1.56
1
A
A
OD1
HG1
ASN
THR
47
49
1.57
2
A
A
HG1
O
THR
GLY
2
27
1.52
2
A
A
O
HG
GLN
SER
5
9
1.53
2
A
A
O
HG
THR
SER
54
56
1.54
2
A
A
O
HG
CYS
SER
62
63
1.58
3
A
A
HG1
O
THR
GLY
2
27
1.47
3
A
A
O
HG
GLN
SER
5
9
1.55
3
A
A
O
HG
THR
SER
54
56
1.56
3
A
A
OD1
HG1
ASN
THR
47
49
1.56
3
A
A
O
HH
GLY
TYR
17
35
1.57
4
A
A
O
HG
GLN
SER
5
9
1.52
4
A
A
O
HG
SER
SER
18
37
1.56
4
A
A
HG1
O
THR
ASN
2
26
1.57
4
A
A
O
HH
GLY
TYR
17
35
1.58
4
A
A
O
HG1
VAL
THR
51
54
1.60
4
A
A
O
HG
GLU
SER
64
65
1.60
5
A
A
O
HG
GLN
SER
5
9
1.54
5
A
A
OD1
HG1
ASN
THR
47
49
1.54
5
A
A
O
HH
GLY
TYR
17
35
1.57
5
A
A
O
HG1
VAL
THR
51
54
1.57
5
A
A
O
HG
HIS
SER
15
18
1.58
5
A
A
O
HG
CYS
SER
62
63
1.58
5
A
A
O
HG
GLU
SER
64
65
1.59
6
A
A
O
HG
GLU
SER
6
9
1.50
6
A
A
HG1
O
THR
GLY
2
27
1.53
6
A
A
O
HG
THR
SER
54
56
1.56
7
A
A
HG1
O
THR
GLY
2
27
1.50
7
A
A
O
HG
GLN
SER
5
9
1.54
7
A
A
O
HG
THR
SER
54
56
1.55
7
A
A
O
HG
CYS
SER
62
65
1.55
7
A
A
O
HH
GLY
TYR
17
35
1.57
8
A
A
HG1
O
THR
GLY
2
27
1.51
8
A
A
O
HG
HIS
SER
15
37
1.51
8
A
A
O
HG
GLN
SER
5
9
1.52
8
A
A
O
HH
GLY
TYR
17
35
1.56
9
A
A
HG1
O
THR
GLY
2
27
1.50
9
A
A
O
HG
THR
SER
54
56
1.54
9
A
A
O
HG
HIS
SER
15
37
1.55
9
A
A
OD1
HG1
ASN
THR
47
49
1.56
9
A
A
O
HG
GLU
SER
6
9
1.56
9
A
A
O
HH
GLY
TYR
17
35
1.56
10
A
A
HG1
O
THR
GLY
2
27
1.50
10
A
A
O
HG
GLN
SER
5
9
1.53
10
A
A
O
HH
GLY
TYR
17
35
1.56
10
A
A
OD1
HG1
ASN
THR
47
49
1.57
10
A
A
O
HG
HIS
SER
15
37
1.57
10
A
A
O
HG1
VAL
THR
51
54
1.58
11
A
A
HG1
O
THR
GLY
2
27
1.50
11
A
A
O
HG
GLN
SER
5
9
1.54
11
A
A
O
HG
THR
SER
54
56
1.54
11
A
A
O
HH
GLY
TYR
17
35
1.57
12
A
A
O
HG
VAL
SER
44
65
1.50
12
A
A
HG1
O
THR
GLY
2
27
1.51
12
A
A
O
HG
GLN
SER
5
9
1.53
12
A
A
OD1
HG1
ASN
THR
47
49
1.55
12
A
A
O
HH
GLY
TYR
17
35
1.56
12
A
A
O
HG
ASN
SER
61
63
1.58
12
A
A
O
HG1
VAL
THR
51
54
1.59
13
A
A
HG1
O
THR
GLY
2
27
1.49
13
A
A
O
HG
HIS
SER
15
18
1.53
13
A
A
O
HG
GLN
SER
5
9
1.53
13
A
A
O
HG
ASN
SER
61
63
1.60
14
A
A
HG1
O
THR
GLY
2
27
1.52
14
A
A
O
HG
CYS
SER
62
65
1.52
14
A
A
O
HG
GLU
SER
6
9
1.57
14
A
A
O
HG1
VAL
THR
51
54
1.59
15
A
A
HG1
O
THR
GLY
2
27
1.50
15
A
A
O
HG
GLU
SER
64
65
1.53
15
A
A
O
HG
GLN
SER
5
9
1.54
15
A
A
O
HG
THR
SER
54
56
1.55
15
A
A
O
HH
GLY
TYR
17
35
1.57
15
A
A
O
HG
HIS
SER
15
18
1.59
16
A
A
HG1
O
THR
GLY
2
27
1.52
16
A
A
O
HG
GLN
SER
5
9
1.53
16
A
A
OD1
HG1
ASN
THR
47
49
1.54
16
A
A
O
HG
SER
SER
18
37
1.55
16
A
A
O
HG
GLU
SER
64
65
1.58
17
A
A
HG1
O
THR
GLY
2
27
1.50
17
A
A
O
HG
GLN
SER
5
9
1.53
17
A
A
OD1
HG1
ASN
THR
47
49
1.55
17
A
A
O
HG
VAL
SER
44
65
1.56
17
A
A
O
HH
GLY
TYR
17
35
1.57
17
A
A
O
HG
THR
SER
54
56
1.57
18
A
A
HG1
O
THR
GLY
2
27
1.52
18
A
A
O
HG
SER
SER
18
37
1.55
18
A
A
OD1
HG1
ASN
THR
47
49
1.55
18
A
A
O
HG
GLU
SER
6
9
1.56
18
A
A
O
HH
GLY
TYR
17
35
1.57
18
A
A
O
HG
GLU
SER
64
65
1.58
19
A
A
HG1
O
THR
GLY
2
27
1.50
19
A
A
O
HG
GLN
SER
5
9
1.52
19
A
A
OD1
HG1
ASN
THR
47
49
1.53
19
A
A
O
HH
GLY
TYR
17
35
1.57
19
A
A
O
HG
CYS
SER
62
63
1.60
20
A
A
O
HG
GLN
SER
5
9
1.52
20
A
A
HG1
O
THR
GLY
2
27
1.55
20
A
A
O
HG1
VAL
THR
51
54
1.57
20
A
A
OD1
HG1
ASN
THR
47
49
1.57
21
A
A
HG1
O
THR
GLY
2
27
1.50
21
A
A
O
HG
GLN
SER
5
9
1.53
21
A
A
O
HG
GLU
SER
64
65
1.56
21
A
A
OD1
HG1
ASN
THR
47
49
1.56
21
A
A
O
HG
SER
SER
18
37
1.58
21
A
A
O
HH
GLY
TYR
17
35
1.59
21
A
A
O
HG
CYS
SER
62
63
1.60
22
A
A
O
HG
GLN
SER
5
9
1.53
22
A
A
O
HG
THR
SER
54
56
1.54
22
A
A
HG1
O
THR
GLY
2
27
1.55
22
A
A
O
HH
GLY
TYR
17
35
1.56
22
A
A
OD1
HG1
ASN
THR
47
49
1.56
23
A
A
HG1
O
THR
GLY
2
27
1.47
23
A
A
O
HG
HIS
SER
15
18
1.52
23
A
A
O
HG
VAL
SER
44
65
1.52
23
A
A
O
HG
GLN
SER
5
9
1.54
24
A
A
HG1
O
THR
GLY
2
27
1.48
24
A
A
O
HG
VAL
SER
44
65
1.53
24
A
A
O
HH
PRO
TYR
16
35
1.55
24
A
A
OD1
HG1
ASN
THR
47
49
1.57
24
A
A
O
HG
THR
SER
54
56
1.57
24
A
A
O
HG
GLY
SER
17
18
1.60
25
A
A
O
HG
THR
SER
54
56
1.53
25
A
A
O
HG
GLN
SER
5
9
1.53
25
A
A
OD1
HG1
ASN
THR
47
49
1.58
25
A
A
HG1
O
THR
GLY
2
27
1.59
26
A
A
HG1
O
THR
GLY
2
27
1.49
26
A
A
O
HG
GLN
SER
5
9
1.52
26
A
A
O
HG
THR
SER
54
56
1.55
26
A
A
O
HH
GLY
TYR
17
35
1.57
27
A
A
HG1
O
THR
GLY
2
27
1.49
27
A
A
O
HG
VAL
SER
44
65
1.54
27
A
A
OD1
HG1
ASN
THR
47
49
1.55
27
A
A
O
HH
HIS
TYR
15
35
1.59
28
A
A
HG1
O
THR
GLY
2
27
1.48
28
A
A
O
HG
VAL
SER
44
65
1.53
28
A
A
O
HG
GLN
SER
5
9
1.55
28
A
A
OD1
HG1
ASN
THR
47
49
1.56
29
A
A
HG1
O
THR
GLY
2
27
1.51
29
A
A
O
HG
GLN
SER
5
9
1.53
29
A
A
OD1
HG1
ASN
THR
47
49
1.55
29
A
A
O
HG
GLU
SER
64
65
1.56
29
A
A
O
HG
SER
SER
18
37
1.58
30
A
A
HG1
O
THR
GLY
2
27
1.46
30
A
A
O
HG
GLN
SER
5
9
1.52
30
A
A
O
HG
THR
SER
54
56
1.55
30
A
A
O
HG1
VAL
THR
51
54
1.56
30
A
A
O
HG
CYS
SER
62
65
1.58
14
A
TYR
35
0.066
SIDE CHAIN
18
A
ARG
20
0.083
SIDE CHAIN
23
A
TYR
35
0.109
SIDE CHAIN
27
A
TYR
29
0.079
SIDE CHAIN
29
A
ARG
55
0.086
SIDE CHAIN
1
3.54
0.50
120.30
123.84
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
2
4.50
0.50
120.30
124.80
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
5
-3.71
0.60
121.00
117.29
A
A
A
CB
CG
CD2
TYR
TYR
TYR
35
35
35
N
6
3.40
0.50
120.30
123.70
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
55
55
55
N
9
3.57
0.50
120.30
123.87
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
11
3.63
0.50
120.30
123.93
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
12
3.53
0.50
120.30
123.83
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
14
3.59
0.50
120.30
123.89
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
15
3.58
0.50
120.30
123.88
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
17
-3.62
0.60
121.00
117.38
A
A
A
CB
CG
CD2
TYR
TYR
TYR
35
35
35
N
19
3.39
0.50
120.30
123.69
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
55
55
55
N
20
3.79
0.50
120.30
124.09
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
22
-4.04
0.60
121.00
116.96
A
A
A
CB
CG
CD2
TYR
TYR
TYR
35
35
35
N
22
4.23
0.50
120.30
124.53
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
57
57
57
N
24
3.02
0.50
120.30
123.32
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
25
-3.96
0.60
121.00
117.04
A
A
A
CB
CG
CD2
TYR
TYR
TYR
40
40
40
N
1
A
VAL
14
-73.92
47.62
1
A
PRO
31
-51.25
-8.53
1
A
ARG
55
-51.69
103.81
1
A
SER
63
-65.81
33.17
1
A
GLU
64
-61.64
4.08
2
A
PRO
52
-69.15
18.82
2
A
ARG
55
-56.77
94.27
2
A
ARG
57
-63.56
1.13
2
A
SER
63
-167.58
62.99
3
A
PRO
52
-70.15
23.20
3
A
ARG
55
-45.54
102.84
3
A
ASN
61
-76.29
49.55
3
A
CYS
62
-56.10
107.87
3
A
GLU
64
-69.63
23.69
4
A
LYS
3
-21.62
-62.14
4
A
HIS
15
-116.40
61.79
4
A
ASN
53
65.11
-5.02
4
A
ARG
55
-60.95
91.89
4
A
ASN
61
-112.11
61.68
4
A
CYS
62
-52.24
106.66
4
A
SER
63
47.22
25.39
5
A
ARG
55
-59.89
106.08
5
A
ARG
57
-65.50
1.50
6
A
PRO
31
-54.45
-9.09
6
A
ASN
53
59.73
6.63
6
A
ARG
55
-42.42
109.21
6
A
GLU
64
-62.63
68.90
7
A
PRO
31
-48.21
-18.76
7
A
ASN
53
61.22
-0.47
7
A
ARG
55
-43.57
95.22
7
A
SER
63
-64.96
18.30
8
A
HIS
15
-111.03
70.87
8
A
ASN
53
65.18
-0.82
8
A
ARG
55
-56.44
98.82
8
A
CYS
62
-65.32
-172.64
8
A
SER
63
-64.70
51.63
8
A
GLU
64
-69.65
32.84
9
A
HIS
15
-111.41
63.68
9
A
ASN
53
59.44
-2.55
9
A
ARG
55
-46.16
99.02
9
A
ARG
57
-79.27
23.33
9
A
GLU
64
-75.34
26.10
10
A
HIS
15
-114.86
53.62
10
A
GLU
25
-64.64
0.15
10
A
ARG
55
-62.83
94.17
10
A
CYS
62
-57.16
105.73
10
A
SER
63
54.29
19.31
11
A
ARG
55
-43.80
103.02
11
A
ARG
57
-69.07
13.72
12
A
HIS
15
-114.36
63.19
12
A
ASN
53
63.84
-1.51
12
A
ARG
55
-54.85
99.17
12
A
CYS
62
-52.74
107.54
13
A
PRO
52
-68.85
23.20
13
A
ARG
55
-57.25
97.94
13
A
CYS
62
-53.45
105.83
13
A
SER
63
-150.05
13.89
13
A
GLU
64
-65.46
7.28
14
A
ASN
53
71.42
-3.62
14
A
ARG
55
-58.10
97.46
14
A
SER
63
49.81
27.09
15
A
PRO
52
-69.16
23.62
15
A
ARG
55
-53.93
101.83
15
A
SER
63
-154.98
20.76
15
A
GLU
64
-70.52
21.44
16
A
HIS
10
-130.51
-33.16
16
A
PRO
16
-43.72
107.45
16
A
PRO
31
-51.39
-9.51
16
A
ASN
53
62.47
-5.23
16
A
ARG
55
-50.23
102.95
16
A
GLU
64
-52.07
22.27
17
A
ASN
53
61.68
-0.24
17
A
ARG
55
-49.76
106.38
17
A
GLU
64
57.44
11.11
18
A
HIS
15
-118.68
53.20
18
A
ARG
55
-52.77
105.17
18
A
GLU
64
48.91
19.15
19
A
PRO
46
-58.82
-2.21
19
A
SER
63
-157.72
19.01
19
A
GLU
64
-77.51
25.18
20
A
CYS
62
-68.12
-176.20
20
A
SER
63
-65.64
74.19
21
A
HIS
15
-113.52
63.20
21
A
ASN
53
59.99
-2.88
21
A
ARG
55
-46.94
106.36
21
A
ARG
57
-89.69
36.23
21
A
SER
63
-159.62
24.63
21
A
GLU
64
-70.97
34.90
22
A
TYR
35
-111.22
77.51
22
A
ASN
53
59.93
3.60
22
A
ARG
55
-46.88
102.83
22
A
ARG
57
-59.99
-4.75
22
A
CYS
62
-68.92
-178.66
22
A
SER
63
-66.95
35.02
22
A
GLU
64
-69.51
66.17
23
A
SER
18
-49.28
107.99
23
A
PHE
19
-152.64
89.10
23
A
ASN
53
59.50
15.15
24
A
SER
18
69.16
107.08
24
A
ASN
53
61.20
-3.03
24
A
ARG
55
-40.35
102.91
24
A
CYS
62
-60.41
95.39
24
A
GLU
64
56.44
19.58
25
A
HIS
15
-111.67
71.87
25
A
ARG
55
-41.17
93.00
25
A
ARG
57
-69.20
9.05
25
A
CYS
62
-60.68
95.51
25
A
SER
63
-89.05
34.43
26
A
ASN
53
59.86
2.24
26
A
ARG
55
-45.27
103.86
26
A
ASN
61
-74.00
39.88
27
A
HIS
15
-118.73
62.04
27
A
PRO
46
-57.72
-5.83
27
A
PRO
52
-69.31
22.57
27
A
ARG
55
-62.51
96.50
27
A
ASN
61
-116.43
78.12
27
A
SER
63
-67.87
60.41
28
A
PRO
52
-71.81
24.01
28
A
ARG
55
-57.10
107.88
28
A
ARG
57
-67.62
7.72
28
A
CYS
62
-46.30
106.95
28
A
GLU
64
-141.09
10.93
29
A
ASN
53
59.50
2.00
29
A
CYS
62
-65.85
98.80
29
A
SER
63
-77.13
23.81
30
A
HIS
15
-112.98
65.53
30
A
ARG
55
-55.64
105.08
30
A
CYS
62
-57.14
98.50
30
A
SER
63
-76.60
31.62
NMR structure of P41icf, a potent inhibitor of human cathepsin L
1
N
N
A
THR
2
A
THR
2
HELX_P
A
ILE
11
A
ILE
11
1
1
10
disulf
2.031
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
23
A
SG
CYS
23
1_555
disulf
2.045
A
CYS
34
A
SG
CYS
34
1_555
A
CYS
41
A
SG
CYS
41
1_555
disulf
2.033
A
CYS
43
A
SG
CYS
43
1_555
A
CYS
62
A
SG
CYS
62
1_555
IMMUNE SYSTEM
ALPHA HELIX, BETA SHEET, DISULFIDE BONDS, IMMUNE SYSTEM
HG2A_HUMAN
UNP
1
210
P04233
LTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSES
210
274
1L3H
1
65
P04233
A
1
1
65
2
anti-parallel
A
LEU
32
A
LEU
32
A
TYR
35
A
TYR
35
A
TYR
40
A
TYR
40
A
CYS
43
A
CYS
43